130 Avoca Street Randwick NSW 2031
Tel: 02 9399 3335 - Fax: 02 9399 9778

avocastreet.com - asmc.net.au - randwickhealth.com - randwickgp.com - familydoctor.sydney

Message from your GPs



We are open our usual hours.

In the interests of patient and staff safety, only vaccinated patients will be seen in-person at the practice. If you have not yet obtained your vaccination, we can look after you via telehealth.

If you have any symptoms including sore throat, fever, cough or runny nose, please call and book a telehealth consult.

Children under 12 will be seen as required (accompanying parents must be fully vaccinated).

We will continue to run vaccination clinics under strict settings.

Stay safe, and do call 93993335 if you have further enquiries.



Our reception is low on staff. Please be patient.
Thank you for your understanding.
MON - FRI7:30 AM - 5:30 PM
SATsee notes
Tuesday 18 January 2022
Dr Kien1 PM - 5 PM
Dr Angela8 AM - 12 PM
Dr Mandy10 AM - 1 PM
Dr Priscilla2 PM - 6 PM

We are OPEN

Please call 02 9399 3335 to speak to our reception.

eastvax.com jabmenow.com

To book your next Pfizer COVID-19 vaccination

please visit our


Dr Priscilla will be on duty on
1st and 3rd Saturdays of each month.
Dr Priscilla is away on holiday until 10 Jan 2022.

NB: Unvaccinated patients can consult only by telephone or video conference calls.


© smh.com.au

Covid-19 Notices
Emergency Numbers
After Hours 13 74 25
Flu Shot
Local Pharmacies

General Information

Gardasil - HPV Vaccination

A vaccine called Gardasil 9 has been developed that protects against nine HPV types which cause around 90% of cervical cancers in women (and the majority of other HPV-related cancers in women), 95% of all HPV-related cancers in men and 90% of genital warts.

HPV-related cancers include almost all cancers of the cervix, and a proportion of cancers of the anus, vulva, vagina, penis and throat.

Gardasil 9 provides fully vaccinated people with protection against nine types of HPV including:

  • types 16 and 18, the two types that cause the majority of HPV-related cancers
  • the five next most common HPV types associated with cervical cancer (types 31, 33, 45, 52 and 58)
  • two non-cancer-causing HPV types (types 6 and 11), which cause 90% of genital warts.

Gardasil 9 is used in the school-based National HPV Vaccination Program (from 2018). It replaced Gardasil, which protected against four HPV types and was in use bewteen 2007 and 2017.

Australia's Professor Ian Frazer and his team at the University of Queensland discovered how to make the vaccine particles, which form the basis of the HPV vaccine.

New HPV vaccine in 2018

  • In 2018 the National Immunisation Program will adopt a new HPV vaccine which protects against 9 HPV types (9vHPV or Gardasil9®) in a 2-dose schedule given at least 6 months apart. This vaccine protects against additional high-risk HPV types to protect against over 90% of cervical cancers in women and also against additional cancers in men.
  • The new 9vHPV vaccine will be available for ordering in early 2018 on NSW Health’s online vaccine ordering system at https://nsw.tollhealthcare.com/

2-dose schedule for any HPV vaccine

  • The latest international studies demonstrate that a 2-dose schedule of any HPV vaccine given to individuals aged 9-14 years at least 6 months apart gives equivalent protection to a 3-dose schedule given at 0, 2 and 6 months for most individuals (see exceptions below).
  • In 2017, a 2-dose 4vHPV vaccine (Gardasil®) schedule has been adopted for Year 7 students in the NSW School Vaccination Program as the second dose of HPV vaccine was deferred to accommodate the urgent roll-out of the Meningococcal W Response Program to Year 11 and 12 students. These students are therefore fully vaccinated and do not need a third dose.
  • Parents are being advised of the schedule change, and those who still wish for their child to receive a third dose in 2017 can obtain it via their GP.
  • A draft updated chapter of the NHMRC’s Australian Immunisation Handbook has been released to incorporate the implementation of the 2-dose HPV schedule in Australia.

Exceptions to 2-dose HPV schedule

  • Some individuals are still recommended to have a 3-dose schedule at 0, 2 and 6 months, including those who receive their first dose of HPV vaccine at 15 years of age or older, and those with significant immunocompromise (detailed advice at www.health.nsw.gov.au/hpv).

Catch-up vaccination up to 19 years

  • Providers can offer free HPV catch-up vaccination to adolescents aged 10-19 years under the Australian Government’s catch-up program (see www.health.nsw.gov.au/immunisation).
  • In 2017, this means a course of Gardasil®, and can be administered as a 2-dose schedule if commenced prior to the 15th birthday, or a 3-dose schedule for those aged 15-19 years.
  • In 2018 providers will be able to offer two doses of free Gardasil9® vaccine to adolescents 10-19 years of age, however adolescents who commence the schedule after their 15th birthday should pay for the third dose.
  • GPs are strongly encouraged to notify each dose of HPV vaccine administered to the National HPV Register.

Further Information
• NSW Health’s HPV website: www.health.nsw.gov.au/hpv
• Contact your local public health unit on 1300 066 055

The information in the above were collected from the internet,
either from government websites or from reasonably reliable health information sources.
They are for general information only and should not replace the need of seeking medical care during illnesses.